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resumo 
 
 
No seio da comunidade científica tem vindo a crescer o interesse pelas plantas 
de sapal, a partir do momento em que as halófitas se começaram a revelar 
como potenciais fontes de novos compostos com atividade terapêutica. O 
objectivo do presente estudo foi avaliar os efeitos de Salicornia ramosissima 
no metabolismo e excreção de ratinhos controlo e aquando da exposição a 
tetracloreto de carbono (CCl4). Para tal, o fígado e os rins foram sujeitos a uma 
avaliação histopatológica. Foi preparado um extrato etanólico liofilizado 
(SREE) a partir das partes aéreas da planta e, juntamente com as suas 
sementes secas (SRS), foram administrados durante três semanas a ratinhos 
macho da estirpe ICR-CD1, divididos da seguinte forma: nos estudos da planta 
per se, dois grupos receberam SREE  e SRS nas doses de 50 mg/kg e 2000 
mg/kg, respetivamente, por via oral; nos estudos de proteção, outros grupos de 
ratinhos foram pré-tratados com SREE (50 mg/kg) ou SRS (2000 mg/kg), 
seguido de uma injeção subcutânea de 0.25 ml de CCl4 (0.2ml/kg) dissolvido 
em azeite, no último dia da experiência; nos estudos de regeneração, outros 
grupos foram pré-tratados com CCl4 nas condições acima descritas, seguido 
do tratamento com SREE (50 mg/kg) ou SRS (2000 mg/kg) por via oral, até ao 
fim da experiência. Foi considerado um controlo negativo para as três 
situações, o qual recebeu unicamente água. Nos estudos de proteção e 
regeneração foi incluído um controlo positivo o qual foi tratado com água no 
período anterior e posterior à administração de CCl4, respetivamente. O SREE 
per se causou severas lesões no fígado e rim, sugerindo que possa existir uma 
fração tóxica no extrato, enquanto o SRS provocou apenas lesões renais. Não 
houve uma efectiva proteção do SREE e SRS contra a toxicidade do CCl4; o 
SREE permitiu uma ligeira recuperação do fígado após a administração do 
tóxico, enquanto o SRS provocou um aumento da mortalidade e foram 
verificadas algumas lesões degenerativas persistentes em ambos os órgãos. 
Embora ainda não sejam totalmente conhecidos os mecanismos biológicos da 
ação de S. ramosissima, as evidências sugerem a necessidade de futuros 
estudos de investigação de forma a elucidar os seus efeitos toxicológicos. 
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abstract 
 
There has been a growing interest in salt marsh plants among scientific 
community since halophytes have been evidencing strong potential as a source 
of novel compounds with therapeutic activity. The aim of the present study was 
to assess the metabolic and excretory effects of Salicornia ramosissima on 
mice under normal and carbon tetrachloride (CCl4) exposure conditions. 
Accordingly, a histopathological evaluation on liver and kidneys was performed. 
A lyophilised ethanolic extract (SREE) was prepared from the aerial portions of 
S. ramosissima, and its dried seeds (SRS) were reduced to powder. These 
extracts were given during 3 weeks to ICR-CD1 male mice divided as follows: 
for the plant effects per se, groups received  50 mg/kg of SREE or 2000 mg/kg 
of SRS suspended in the drinking water; for protection studies, mice received a 
pre-treatment of SREE (50 mg/kg) or SRS (2000 mg/kg), followed by a single 
0.25 ml subcutaneous injection of CCl4 in olive oil (0.2 ml/kg) on the last day; 
for regeneration studies, animals received a pre-treatment with CCl4 in the 
conditions described above, followed by SREE (50 mg/kg) or SRS (2000 
mg/kg) suspended in the drinking water until the end of the experiment. A 
negative control group was considered for the three settings, which received 
exclusively tap water. A positive control was included in protection and 
regeneration studies in which mice received tap water after and before CCl4 
administration, respectively. SREE per se caused severe hepatic and renal 
damage, suggesting that SREE may contain a toxic fraction, whereas SRS 
displayed only kidney injury. SREE and SRS evidenced no effective protection 
against CCl4-exposed mice; SREE had a little positive influence in the outcome 
of liver recovery after CCl4 administration, whereas SRS increased mortality 
and liver and kidney impairment was still noticed. Although the biological 
mechanisms of S. ramosissima are not fully understood, the evidences suggest 
the pertinence of developing further research on S. ramosissima extracts in 
order to elucidate their toxicological effects. 
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 I. Introduction 
1. The importance of natural plant resources to human 
welfare 
Since ancient times, the humankind has been trying to understand and make use of 
natural resources of the planet, especially plants (Ahmad et al. 2006). Of the 270 000 
terrestrial plant species on earth (Tan et al. 2006), around 10 000 species of higher plants 
are currently used on a wide range of therapeutic purposes (McChesney et al. 2007). 
Despite the popularity of chemically synthesised drugs by pharmaceutical industry, 80% of 
the total human population still treat their health problems with traditional remedies based 
mainly made on plants, according to the World Health Organization (WHO) (Morales 
1996). In fact, the population growth, inadequate supply of drugs, prohibitive cost of 
treatments, side effects and development of resistance to currently used drugs for 
infectious diseases have led to the increasing use of phytotherapy for a wide variety of 
human ailments (Ahmad et al. 2006).  
The practice of traditional medicine is based on the folk knowledge, passed down 
from generation to generation by word of mouth while the documentation of medicinal 
plants is a developing field and the properties of them are still unknown (Ahmad et al. 
2006; Neves et al. 2009). The Portuguese origins of folk medicine are scattered and have 
been, in the recent past, replaced by conventional medical practise (Neves et al. 2009). 
Having also the option for planting crops and consuming processed food, they no longer 
gather wild edible plants as before (Pardo-de-Santayana et al. 2007). However, it is now 
globally known that natural products, such as wild plant resources, represent a rich supply 
of biologically active compounds and are an example of molecular diversity, with 
significant potential in the discovery and development of new medicine (Harvey 2000). 
These bioactive compounds, also known as phytochemicals, are secondary metabolites, 
able to modulate molecular and cellular responses through interaction with many different 
molecular and cellular targets (Milner 2004). Hence these interactions can promote health, 
providing for instance, beneficial antioxidant and enzyme inhibitory or modulatory 
activities to the human body (Huang et al. 1994). 
For this reason, it is necessary to conduct more research on herbal products’ 
quality, safety and efficacy whose scientific recognition might lead them to a definitive 
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 I. Introduction 
integration into conventional medical practise and thus a better alternative to improve 
human welfare (Mendonça-Filho 2006). 
 
1.1. Herbal medicine in the treatment of liver diseases 
The liver is continuously exposed to environmental toxicants, alcohol and 
pharmacological drugs, whose diseases pose currently a serious challenge to public health 
(Adewusi et al. 2010). Chronic liver diseases, such as viral hepatitis B and C, alcoholic 
liver disease, non-alcoholic fatty liver disease and hepatocellular carcinoma, are among the 
leading causes of death in Western countries (Kim et al. 2002). Also conventional and 
modern medicine fails to act in response due to the lack of drug availability and 
effectiveness, only displaying symptomatic relief, the existence of side-effects associated 
with prolonged usage and high probability of relapse if the therapy is discontinued.  As a 
result, there has been an increasing interest in plant-derived hepatic therapies which are 
more accessible and apparently less hazardous (Stickel et al. 2007). Unlike conventional 
medications, which generally consist of a standardized formulation of a specific agent in a 
known concentration, herbal preparations often consist of mixtures of different ingredients, 
frequently in impure form and varying concentration (Stickel et al. 2005). In addition to 
different harvest seasons, sites and extract methods, herbal contamination with 
microorganisms, pesticides or heavy metals may also contribute to hepatotoxic reactions 
(De Smet 2002). Therefore, rigorous scientific testing and appropriate regulations are 
needed to evaluate the potential benefits and hazards of herbal preparations (Stickel et al. 
2007). Despite these limitations, a number of herbals show promising effects in the 
treatment of acute and chronic liver diseases, including for instance silymarin, extracted 
from Silybum marianum, as a potential antifibrotic (Boigk et al. 1997), Phyllantus amarus 
as an antiviral in chronic hepatitis B (Ott et al. 1997) or glycyrrhizin, an extract of 
Glycyrrhiza glabra, as a hepatoprotectant in chronic hepatitis C (Kumada 2002). 
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 I. Introduction 
2. Medicinal halophytes 
Over the last decades, considerable scientific and commercial interest has focused 
on marine natural resources, which might constitute new sources for, among other 
applications, pharmaceuticals (Becker et al. 2008; Newman et al. 2006; Smit 2004), 
enzymes (Pennisi 1997) or functional foods (Zhang et al. 2012).  
Salt marshes have been the subject for extensive biological research over many 
years. Located in estuaries, tidal inlets and in other coastal areas, they are a physical 
boundary between land and sea which provide an exclusive habitat for a large number of 
species that cannot survive in other environments. Salt marsh plants were recognized as 
one of the most important ecosystems communities in a tidal zone because they play vital 
roles in the tidal ecology, such as serving as buffers, protecting the shorelines from erosion 
caused by the force of waves, and filtering contaminants from the land (Townend et al. 
2011; Vernberg 1993). 
Halophytes (halo= salt + phyte= plant), which are plants capable of completing 
their life cycle under highly saline conditions, are found in many salt marshes around the 
world (Yensen 2006). There are more than 2500 halophyte species known and among 
them, several could be suitable candidates to be used as edible plants, fodder, biofuel, 
medicine, chemicals and ornamentals (Abdelly et al. 2006). Interestingly, numerous 
halophyte species have been used in folk medicine (Qasim et al. 2010) and, recently, 
extracts from halophytes have proven activity against human, animal, and plant pathogens 
and more investigations have been carried out to identify the metabolites responsible for 
their bioactivities (Falleh et al. 2011; Gnanadesigan et al. 2011; Oueslati et al. 2012). 
Unfavourable environmental conditions, such as salt-induced stress, increase 
production and accumulation of reactive oxygen species (ROS) in plants, which lead to 
cellular damage, metabolic disorders, and aging processes (Menezes-Benavente et al. 
2004). Due to its powerful antioxidant system, halophytes are able to tolerate and quench 
these toxic ROS (Ben Amor et al. 2007) by inhibiting the initiation or propagation of 
oxidative chain reactions and consequently, delaying the oxidation of lipids and other 
biomolecules (Tepe et al. 2006). Since the natural antioxidants contained in halophytes 
exhibit a strong biological activity, their identification is a promising, safer and economical 
 13 
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alternative for their use in preventive medicine to replace synthetic antioxidants such as 
butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) (Tadhani et al. 
2007). Although some phytochemical bioactive compounds are less effective than those in 
pharmaceutical drugs, their regular ingestion in significant levels through the diet may lead 
to long-term physiological effects (Espin et al. 2007). 
In summary, halophytes have proven strong potential as a new source of novel 
compounds with beneficial proprieties, and are one step further of being a source of health 
products for food and pharmaceutical industries. 
 
2.1. Salicornia species as medicinal plants 
The highest percentage of halophytic genera 
(around 44%) and the largest number of species 
belong to the Chenopodiaceae family (Flowers et al. 
1986). The genus Salicornia, (Chenopodiaceae), is 
world-widely distributed in saline environments and 
found on every continent with the exception of 
Antarctica (Shepherd et al. 2005). Salicornia is 
represented in Portugal by only one species, 
Salicornia ramosissima J. Woods (Castroviejo et al. 
1990). This annual edible halophyte, included in the 
species aggregate S. europaea agg. is broadly 
distributed in the salt marshes and salt pans of Ria de 
Aveiro and also present in many salt marshes of the Iberian Peninsula (Castroviejo et al. 
1990; Silva et al. 2007). This species is characterised by articulated photosynthetic 
succulent stems and distinctive reduced leaves in each segment of the stem. These 
inflorescences are spike-like with two opposite three-flowered cymules in each segment, 
which produce small seeds in the two lateral flowers and a larger seed in the central flower 
of the cymule (seed dimorphism) (Davy et al. 2001). 
Little information is available about S. ramosissima constituents and biological 
activities.  However, a previous study conducted on our laboratory has shown adverse 
hepatic and renal effects of a S. ramosissima ethanolic extract on mice, mainly severe 
cellular degeneration and haemorrhages (Ferreira et al.  2012).  
Figure 1 - S. ramosissima in vegetative 
stage (Aveiro, Portugal). 
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Regarding medicinal properties, S. europaea is known in folk medicine for the 
treatment of numerous ailments, including hypertension, cephalalgia, and scurvy (State 
Administration of Traditional Chinese Medicine of PRC in Yin et al. 2012), and S. 
herbacea in Asia as a treatment for hepatitis, nephropathy, diarrhea or constipation (Rhee 
et al. 2009), obesity, diabetes, cancer, asthma or even arthritis (Lee et al. 2006). The 
biological mechanisms for the majority of these activities have not been totally clarified.  
Currently, it is still used as a seasoned vegetable by some people living in coastal 
areas; its aerial parts are used as an ingredient of vinegar in Western Europe and, in Korea, 
consumed in diverse forms, such as a seasoned vegetable, salad and fermented food (Kim 
et al. 2011). Due to the recent discovery of new, functional and biological active 
compounds with beneficial effects, consumption of this plant has been extended into the 
functional foods and medicinal herb category (Rhee et al. 2009). Despite all of this, there is 
still a lack of public awareness and scientific literature regarding successfully established 
halophytes such as Salicornia (Böer 2006). 
 
2.1.1. Bioactive chemical compounds 
Several studies on the nutritional value of Salicornia have characterised the 
chemical composition of the whole plant, aerial parts, or seeds and their amount through 
assessment of a variety of solvent extracts. Indeed, many valuable primary and secondary 
compounds have been found and identified. On the whole, this genus is  characterised by 
relatively high protein content, carbohydrates, fibres and considerable presence of 
aminoacids (aspartic acid, glutamic acid, arginine and essential aminoacids such as leucine, 
isoleucine or valine); minerals are represented by the presence of sodium, potassium, 
calcium, magnesium and chloride in considerable amounts (Durant et al. 2006; Lu et al. 
2010; Rhee et al. 2009). Many phytochemicals were isolated and identified from S. 
herbacea aerial or whole plant, such as flavonol glucosides of quercitin and isorhamnetin, 
chlorogenic acid derivatives, triterpenoid saponins and some sterols (Kim et al. 2011; Kim 
et al. 2012; Lee et al. 2004). Triterpenoid saponins can also be found in fresh S. europaea 
(Yin et al. 2012). Fresh whole S. bigelovii contains beta-carotenes and ascorbic acid 
(vitamin C) (Lu et al. 2010), while nortriterpenoid saponins and triterpenoid glycosides 
were recently found in dry specimens (Wang et al. 2012). Lipid content is generally not 
abundant in the whole plant but S. bigelovii and S. brachiata have been cultivated for 
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animal fodder and their seeds exceptionally used for oil production in Middle East over the 
past years (Charnock et al. 1988; Eganathan et al. 2006). Detailed studies on seed oils from 
S. bigelovii and hybrid varieties SOS-7 and -10 have revealed a significant amount of 
proteins, natural antioxidants (tocopherols and flavonoids), sterols (7-stigmastenol, b-
sitosterol, spinasterol) and polyunsaturated fatty acids, particularly linoleic acid, which is 
known to have a great value in human nutrition (Anwar et al. 2002; Attia et al. 1997; 
Elmallah et al. 1994; Elshami et al. 1993; Glenn et al. 1991). A S. europaea seed profile 
had been previously characterised revealing a fatty acid composition similar to the above 
described. Additionally, sucrose, nitrogen, mineral phosphate, potassium and magnesium 
were represented significantly (Austenfeld 1986). 
 
2.1.2. Biological and pharmacological activities 
Several studies reported the value of extracts and some active constituents of 
Salicornia species, each presenting considerable biological and pharmacological activities, 
such as antioxidative (Kim et al. 2011), anti-inflammatory (Kim et al. 2009), anti-
hyperlipidemic (Hwang et al. 2007; Park et al. 2012), anti-hyperglycemic (Park et al. 
2006), antithrombotic (Jang et al. 2007), antitumor (Kang et al. 2011; Kong et al. 2008; 
Wang et al. 2012), among others.  
An aqueous extract of S. herbacea was shown to be capable of minimising ROS-
induced cell damage and recovering liver injury in an ovariectomised rat model of 
oxidative stress, through induction of antioxidant enzyme levels (Ha et al. 2006); various 
fractions from a seed extract were recently reported to inhibit lipid peroxidation and 
exhibit significant cytotoxic effects on human colon cancer cells while being less toxic to a 
non-cancerous intestinal cell line (Kang et al. 2011). Another potential chemopreventive 
agent for cancer is isorhamnetin 3-O-β-D-glucoside, a flavonoid compound extracted also 
from S. herbacea which is able to block the proteolytic activities of metalloproteinase 
enzymes and enhances a metalloproteinase inhibitor molecule, important in impeding 
malignant tumour progression (Kong et al. 2008). 
Isorhamnetin 3-O-β-D-glucopyranoside and quercetin 3-O-β-D-glucopyranoside, 
have also been confirmed to prevent and treat streptozotocin-induced diabetes in rats, by 
inhibiting an enzyme involved in the pathogenesis of diabetic complications (Lee et al. 
2005). Tungtungmadic acid (3-caffeoyl-4-dihydrocaffeoylquinic acid), isolated as an 
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antioxidant from S. herbacea, showed a protective effect against tert-butyl hydroperoxide-
induced hepatotoxicity in Hepa1c1c7 cells, increasing the cellular antioxidant defence 
capacity (Hwang et al. 2009) and was found to have anti-inflammatory properties on 
murine macrophage cells exposed to the tumour promoter phorbol 12-myristate 13-acetate 
(PMA) (Han et al. 2010). 
Finally, polysaccharides originated from S. herbacea evidenced potent 
immunomodulatory activity on monocyte/macrophage lineage cells, which is an important 
step for the triggering of the immune response. This leads to the recruiting of other 
immune cells and upregulation of cytolytic molecules against a variety of tumours (Im et 
al. 2007; Lee et al. 2006). Moreover on another study, these compounds provoked cell 
cycle arrest and apoptosis on human colon cancer cells, evidencing an anti-proliferative 
activity. Therefore, polysaccharides might be one of the main reasons for S. herbacea anti-
cancer effects (Ryu et al. 2009). 
The literature thus confirms the importance of these naturally-occurring dietary 
compounds as interesting resources for health promotion through its various physiological 
actions on animals, cultured cells and chemical assay systems. 
 
 
3. Toxicity studies 
Several studies have been conducted to investigate the protective or regenerative 
potential of plant extracts, by inducing cell damage through toxic agents. A toxic agent 
most commonly used in laboratory experiments is carbon tetrachloride, whose 
histopathological effects are well documented. 
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3.1. Carbon tetrachloride 
Carbon tetrachloride (CCl4) is a colourless liquid halogenated alkane, synthetically 
produced and once widely used as a solvent, fumigant, cleaner and degreaser, both for 
industrial and home handling. Due to its severe toxic effects, most of these uses were 
discontinued in the past (Bergman 1979). Although CCl4 is no longer employed for such 
purposes, it is the best characterised system of xenobiotic-induced hepatotoxicity and 
animal models are frequently used for the screening of anti-hepatotoxic and/or 
hepatoprotective activities of drugs and herbal extracts (Jain et al. 2012; Rubinstein 1962; 
Rusu et al. 2005). 
CCl4 poisoning can occur by inhalation, ingestion or dermal contact and, depending 
on the dose and period of exposure, it covers a variety of effects. The injuries of haloalkane 
exposure are even worsened by their inherent tendency to display synergism with certain 
solvents or chemicals, leading to potentiation of some aspects of toxicity (Plaa 2000). 
Although hepatic toxic effects are the predominant clinical features following 
exposure to CCl4, other systemic (renal, respiratory and cardiovascular), reproductive and 
central effects and nervous system depression have been reported (Ahmad et al. 1987; 
Weber et al. 2003). 
 
3.2. The liver and its pathological changes 
The liver is the largest gland in the human body, representing nearly 2% of an 
adult’s body weight. Anatomically, it is characterised by two main lobes and two minor 
ones. It acts as an interface between the digestive system and the blood; the position of the 
liver in the circulatory system is optimal for gathering, transforming, and accumulating 
metabolites from blood and for neutralising and eliminating toxic substances, through the 
bile (Mescher 2009). It also plays an important role in the carbohydrate and lipid 
metabolism, for instance, glycogen storage, triglycerides and cholesterol synthesis, and in 
protein (albumin, carrier proteins and clotting factors) synthesis (Fox 2006). 
The liver is surrounded by a collagenous capsule which becomes continuous with 
the internal stroma of the liver at the hilus, the region where the portal vein and hepatic 
artery enter the organ and the hepatic and lymphatic ducts exit (Mescher 2009; Rogers et 
al. 2012). 
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The structural and functional units of the liver, the hepatic lobules, are polyhedral 
structures which contain hepatocytes arranged into radial interconnected plates or cords. 
Each hepatic lobule displays several portal tracts at the periphery and a central vein. The 
portal zones are located at the corners of the lobules and consist of a portal triad structure 
embedded in collagenous connective tissue: a venule branch from the portal vein, an 
arteriole from the hepatic artery and a duct of cuboidal epithelium from the bile duct 
system. Blood flows from the periphery to the centre of each hepatic lobule, first supplying 
periportal hepatocytes with oxygen and metabolites, which are more active in protein 
synthesis, while centrilobular ones remain less exposed to nutrients and are more involved 
with detoxification and glycogen metabolism. Mono or binucleated hepatocytes secrete 
bile into minuscule tubular spaces between them, the bile canaliculi, which anastomose 
into the common bile duct, where bile is excreted into the duodenum (Mescher 2009). 
The spaces among hepatic cords are the liver sinusoids, formed by a discontinuous 
layer of fenestrated endothelial cells and supported by reticular fibres of type III collagen. 
In sinusoids reside stellate Ito cells, which store vitamin A in lipid droplets, macrophage 
Küpffer cells, which filter foreign particulate matter entering the liver and break down 
aged erythrocytes, and other cells involved in immune surveillance. Between the sinusoid 
and the hepatocyte is the perisinusoidal space of Disse, where free exchange of 
macromolecules between plasma and hepatocytes occurs (Rogers et al. 2012). 
The liver is the main target organ for CCl4 deleterious effects. Briefly, the main 
CCl4-induced changes in the liver are the impairment of membrane permeability, 
activation of lipid peroxidation, impairment of triglycerides secretion, resulting in steatosis 
(fatty degeneration), and inhibition of protein synthesis, which contribute to the breakdown 
of membrane structure and loss of organelle and cell functions. When the injury is 
relatively mild, it may be reversible; however, in severe cases and prolonged exposure, it 
leads to a complete destruction of hepatocytes and a subsequent decrease in liver function, 
culminating in liver fibrosis, cirrhosis or hepatocellular carcinomas (Weber et al. 2003). 
 
3.3. The kidney and its pathological changes 
The kidney is a bean-shaped organ from the urinary system, lying in the upper 
retroperitoneal area of the body. Its main functions include the maintenance of water, 
electrolyte and acid-base homeostasis, renin and erythropoietin synthesis, and the excretion 
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of many toxic metabolic waste products in the urine, particularly urea and creatinine 
molecules (Treuting et al. 2012; Young et al. 2006).  
The kidney is divided into two zones, an outer cortex and an inner medulla. In 
humans, the renal medulla consists of several conical structures called renal pyramids, 
which are separated by medullary extensions of the cortex. Each medullary pyramid, along 
with the cortical tissue at its base and along its sides, constitutes a renal lobe (Mescher 
2009). 
The functional and structural unit of the kidney is the nephron, which performs 
osmoregulation and excretion by the processes of filtration, selective absorption and 
secretion (Young et al. 2006). Histologically, it consists of a renal corpuscle, responsible 
for plasma ultrafiltration in a globular network of anastomosing capillaries, called the 
glomerulus; this structure is surrounded by a double-walled epithelial capsule, the 
Bowman's capsule. It also contains a renal tubule of a convoluted shape and lined by a 
single layer of epithelial cells. It has four distinct zones, each having a different 
histological appearance and roles in tubular function, related to the selective reabsorption 
of water, inorganic ions and other molecules from the ultrafiltrate: the proximal convoluted 
tubule, the loop of Henle (with descending and ascending limbs), the distal convoluted 
tubule and the collecting tubule (Mescher 2009; Young et al. 2006). 
Briefly, nephrons arise in the cortex, descend into the medulla and return to the 
cortex. The collecting ducts receive the fluid and descend again into the medulla to 
discharge urine from renal papilla, subsequently funnelled through the renal pelvis and out 
of the kidney in the ureter (Young et al. 2006). 
Because of its high rate of perfusion, active transport capabilities and concentrating 
functions, the kidney often is exposed to higher concentrations of chemicals and toxicants 
than other organs. The kidney is capable of metabolically altering a wide variety of 
endogenous and exogenous substances, and chemicals such as CCl4 may produce a direct 
renal cytotoxicity through the conversion of its toxic products via cytochrome P450 
enzyme metabolism, or indirectly by altering renal haemodynamics, or by a combination of 
both. The site along the injured nephron is regularly the site of cellular accumulation of the 
chemical or its metabolites, whose effects are predictable and dose-related (Kluwe et al. 
1980; Lock 2009). 
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4. Framing and purpose of the experimental study 
Overall, the importance of Salicornia species is being recently widespread, through 
the recognition of its nutritional value and effects of its chemical compounds. Currently 
many traditional remedies from plant sources are tested for its potential antioxidant effects, 
which are important in the recovery processes of the intoxicated liver (Giri et al. 2011; 
Rusu et al. 2005). About the medicinal properties of S. ramosissima, little is known so far. 
However, other Salicornia species were reported to have beneficial health effects, so it is 
likely that S. ramosissima would be included in that frame as well.  
The general goal of this study was to assess the influence of S. ramosissima on 
organism metabolic and excretory systems, under toxicological conditions and focusing on 
liver and kidney impairment and recovery. The chosen animal model was the mouse since 
it is often used as a laboratory research animal due to easy maintenance, short life cycle 
and a well-known physiology (Ng 2008). Moreover, bioactivation of CCl4 is similar 
between rodents and humans (Thrall et al. 2000). Therefore, mice were subjected to CCl4, 
already described as a potent hepatotoxic substance. The prospective hepatoprotection and 
hepatoregeneration of S. ramosissima, along with the effects in the kidneys, were evaluated 
by histological analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
II. Material and 
Methods 
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1. Plant treatment and extract preparation 
Fresh specimens of S. ramosissima were collected on 28th October 2011 at 
Troncalhada salt pan, Ria de Aveiro. Samples were identified by Professor Helena Silva 
from University of Aveiro, Portugal. After rinsed with distilled water, samples were stored 
at -20°C until further use. 
The fresh aerial parts (1.2 kg) of S. ramosissima were chopped into small pieces 
and extracted with ethanol p.a. (EtOH, 5 L, three times) at room temperature for 24h using 
an overhead stirrer (Yellow line OST basic, IKA®-Werke GmbH & Co. KG, Germany). 
The mixture was filtered and the ethanolic extract was obtained. The solvent was removed 
using a rotary vacuum evaporator (Laborota 4000, Heidolph, Germany) at 50°C. The 
resulting extract was then freeze-dried at - 40°C (Flexi-Dry MP, FD-3-85A-MP model, 
FTS Systems, Stone Ridge, USA) for 5 days, yielding 34.7 g of lyophilised product. 
Additionally, dried specimens of S. ramosissima were collected on 11th November 
2011 at Troncalhada salt pan, Ria de Aveiro, and further air-dried at room temperature for 
1 week. 
In order to retrieve seeds, the dried plants were shaken vigorously into a plastic tray 
and the remains were passed through 2 and 1 mm sieves, and then through 500 and 355 μm 
sieves to clean the sample from residues. The resultant amount of seeds (115 g) was 
homogenised to a fine powder with a blender and stored at room temperature.  
 
 
2. Animal handling 
All animal experiments followed the guidelines for the care and handling of 
laboratory animals. Five-week-old male ICR(CD-1®) mice (Mus musculus L.), supplied 
by Harlan laboratories (Harlan, Barcelona, Spain) and weighing 34,71 ± 3,83g, were 
housed in polycarbonate cages placed in an acclimatised chamber suitable for small 
rodents under standard conditions: constant temperature of 22 ± 2°C, relative humidity of 
40-60%, and 12h light/dark photoperiod. Mice were fed with regular rodent chow (SAFE-
Scientific Animal Food & Engineering, Augy, France) and tap water ad libitum. The 
acclimatisation period to laboratory conditions lasted for 5 days. 
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Animals were randomly divided into 9 experimental groups of 4-5 mice each: 
→ Group I: negative control, treated with tap water ad libitum; 
→ Group II: treated orally with ethanolic extract of S. ramosissima, suspended in the 
drinking-trough water, at a dose of 50 mg/kg b.w; 
→ Group III: treated orally with powdered dried seeds of S. ramosissima, suspended 
in the drinking-trough water, at a dose of 2000 mg/kg b.w; 
→ Group IV: positive control, treated with tap water ad libitum, followed by 0.25 mL 
of a CCl4 solution (olive oil as a vehicle) at a single dose of 0.2 mL/kg b.w. on the 
22th day; 
→ Group V: treated orally with ethanolic extract of S. ramosissima, suspended in the 
drinking-trough water, at a dose of 50 mg/kg b.w, followed by 0.25 mL of a CCl4 
solution (olive oil as a vehicle) at a single dose of 0.2 mL/kg b.w. on the 22th day.  
→ Group VI: treated orally with powdered dried seeds of S. ramosissima, suspended 
in the drinking-trough water, at a dose of 2000 mg/kg b.w, followed by 0.25 mL of 
a CCl4 solution (olive oil as a vehicle) at a single dose of 0.2 mL/kg b.w. on the 
22th day. 
→ Group VII: positive control, treated with 0.25 mL of a CCl4 solution (olive oil as a 
vehicle) at a single dose of 0.2 mL/kg b.w., followed by tap water ad libitum;  
→ Group VIII: treated with a with 0.25 mL of a CCl4 solution (olive oil as a vehicle) 
at a single dose of 0.2 mL/kg b.w, followed by oral administration of the ethanolic 
extract of S. ramosissima, suspended in the drinking-trough water, at a dose of 50 
mg/kg b.w. 
→ Group IX: treated with 0.25 mL of a CCl4 solution (olive oil as a vehicle) at a 
single dose of 0.2 mL/kg b.w, followed by oral administration of the powdered 
dried seeds of S. ramosissima, suspended in the drinking-trough water at a dose of 
2000 mg/kg b.w. 
The study was carried out for 3 weeks (22 days) and mice were weighed at the start 
of the experiment, once a week and at the sacrifice moment, with an accuracy of 0,1g. 
Animals were sacrificed by cervical dislocation 24h after the last treatment on each group. 
CCl4 solution was administered by subcutaneous injection and its dosage was retrieved 
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from Irie and co-workers (2010). The ethanolic extract dosage was adapted from Pinto 
(2011) while the seed dosage was based on Meneguetti and co-workers (2011). 
The experimental study is summarised below: 
 
Table 1 – Structure of the experimental design. 
Group Study type Treatment given Plant dosage 
CCl4 
dosage 
Group I Negative (normal) control Tap water N/A N/A 
Group II  Aerial plant extract experimental group S. ramosissima EtOH extract 50 mg/kg  N/A 
Group III  Dried seed experimental group S. ramossisima dried seeds 2000 mg/kg N/A 
Group IV  Positive control  for protection group Tap water + CCl4  N/A 0.2 mg/kg  
Group V  Protection experimental group 
S. ramosissima EtOH extract 
+ CCl4  
50 mg/kg. 0.2 mg/kg  
Group VI  Protection experimental group 
S. ramossisima dried seeds + 
CCl4  
2000 mg/kg  0.2 mg/kg  
Group VII Positive control for regeneration group CCl4 + tap water N/A 0.2 mg/kg. 
Group 
VIII 
Regeneration 
experimental group 
CCl4 + S. ramosissima EtOH 
extract 50 mg/kg  0.2 mg/kg  
Group IX Regeneration experimental group 
CCl4 + S. ramossisima dried 
seeds 2000 mg/kg  0.2 mg/kg 
 
 
3. Organ collection and histological techniques 
After opening the abdominal cavity, the liver and kidneys were excised from mice 
and weighed (AND model HR-120). Portions and left sides of the aforementioned organs 
were used for histological studies. Firstly, they were immersed in Bouin’s solution for 
fixation purposes. Subsequently, dehydration was performed through graded ethanol series, 
followed by infiltration and embedding in paraffin (melting point 52-58°C). Sections of 4-
8 µm thickness were prepared from the tissues using a rotary microtome (Leitz 1512, 
Wetzlar, Germany). The samples were dried in a stove (40°C) then deparaffinised and 
rehydrated. Sections were stained with hematoxylin and eosin dyes and received further 
dehydration and clearing with xylene. The preparations were mounted in the Eukitt® 
synthetic medium (EMS, Hatfield, USA) and examined microscopically for cell 
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abnormalities (Olympus microscope model BX41TF, coupled with photographic system, 
Japan). 
4. Histological semi-quantitative analysis 
Histological lesions of liver and kidney were graded according to a previously 
described semi-quantitative score (Shackelford et al. 2002). One slide section of each 
organ for each group was considered. The lesion’s score was evaluated as follows: 0: Not 
present, 1: Minimal (< 10%), 2: Mild (10–39%), 3: Moderate (40–79%), 4: Marked (80–
100%). 
 
5. Statistical analysis 
All values are presented as mean ± standard error (SE). The results were computed 
statistically (IBM SPSS Statistics, version 20.0.0, IBM Corp.) using two-way ANOVA 
without interactions (incomplete factorial design) to analyse differences between mean 
values of relative organ weights, among groups. Since relative weight is a more sensitive 
toxicity indicator than absolute weight (Uemitsu et al. 1986), the latter was deliberately 
excluded from statistical testing. A p-value <0.05 was considered significant.  
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 III. Results 
The results herein described attempted to elucidate the effects of S. ramosissima 
ethanolic extract (SREE) and seeds (SRS) on the liver and kidney structure and function 
under normal and toxicological conditions. 
 
1. Mice survival and behaviour 
All mice have survived during the present study, except in the groups V and IX 
where 25% and 75% of mortality was noted, respectively. Deaths occurred between 24h 
and 7 days after CCl4 administration. No significant changes in mice behaviour and 
physical appearance from groups I to III were observed; however, all mice exposed to 
CCl4 presented, 24h after the injection, pilo-erection, less activity and weak response to 
handling. Mice from groups VII, VIII and the remaining from group IX recovered 
gradually until the end of the experiment. 
 
2. Organ weight 
Table 2 represents the liver and kidneys absolute weights from all experimental and 
control groups. 
 
Table 2 – Values of the absolute organ weights from all groups. 
Group 
Absolute organ weight (g) n 
Liver Right kidney Left kidney 
Group I (control) 2,2963±0,0876 0,2762±0,0116 0,2683±0,0183 4 
Group II (SREE) 2,3725±0,1564 0,2559±0,0205 0,2599±0,0245 4 
Group III (SRS) 1,5844±0,0760 0,2242±0,0053 0,2154±0,0065 4 
Group IV (water + CCl4) 2,1693±0,1500 0,2888±0,0123 0,2807±0,0120 5 
Group V (SREE + CCl4) 2,0689±0,1727 0,2475±0,0327 0,2344±0,0259 3 
Group VI (SRS + CCl4) 1,9372±0,0600 0,3082±0,0186 0,3055±0,0255 4 
Group VII (CCl4 + water) 2,0719±0,0757 0,2954±0,0168 0,2897±0,0104 4 
Group VIII (CCl4 + SREE) 1,0700±0,1151 0,1795±0,0152 0,1754±0,0101 4 
Group IX (CCl4 + SRS) 1,7397±ND 0,2739±ND 0,2696±ND 1 
Data are mean ± SE values.  
n, number of animals; ND, not determined. 
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Table 2 shows a stable kidney weight in all the groups. On the other hand, there 
was more variability in the liver weight among groups. However, only statistical 
significant differences among the different groups were measured in the organ-to-body-
weight ratio due to the reasons described earlier. 
Table 3 shows the mean values of the relative organ weight (in percentage) from 
the several experimental and control groups, as well as the results of the statistical test.  
Table 3 - Comparison of the relative organ weights of experimental and control groups. 
Group 
Final body weight 
(g) 
Relative organ weight (g/g of the body weight, %) 
Liver Right kidney Left kidney 
Group I  
(control) 
38,325±1,114 5,9898±0,1326 0,7217±0,0306 0,6998±0,0436 
Group II  
(SREE) 
36,775±1,344 6,4404±0,2756 0,6973±0,0546 0,7055±0,0545 
Group II  
(SRS) 
32,018±0,842 4,9505±0,2275 0,7024±0,0321 0,6749±0,0335 
Group IV  
(water + CCl4) 
37,960±1,003 5,6979±0,3036 0,7615±0,0305 0,7390±0,0222 
Group V  
(SREE + CCl4) 
38,000±1,436 5,4577±0,4901 0,6490±0,0701 0,6152±0,0535 
Group VI  
(SRS + CCl4) 
42,375±1,967 4,5848±0,1272 0,7267±0,0181 0,7192±0,0368 
Group VII  
(CCl4 + water) 
41,050±1,201 5,0497±0,1429  0,7200±0,0363 0,7060±0,0191 
Group VIII  
(CCl4 + SREE) 
27,173±2,310 3,9166±0,1140 0,6658±0,0476 0,6529±0,0406 
Group IX  
(CCl4 + SRS) 
33,923± ND 5,1319± ND 0,8080± ND 0,7953± ND 
Data are mean ± SE values (n=4). Group IV (n=5), Group V (n=3), Group IX (n=1). 
ND, not determined. 
 
No statistical significant differences were observed in the relative kidney weight 
among the presented groups (plant treatment per se, protection studies and regeneration 
studies). Although the relative liver weights, mainly from group II, VI and VIII, were 
lower than their respective controls, these differences had no statistical significance. Due to 
the low survival rate, Group IX was excluded from statistical analysis. 
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3. Macroscopic aspect of the organs 
The liver and kidneys of all groups exhibited normal morphology, except for CCl4-
treated livers, which displayed pale colour and were slightly mottled, 24h after the 
administration of the toxicant. 
 
4. Histopathological findings 
The histopathological effects of S. ramosissima ethanolic extract and whole seeds 
were evaluated on the liver and kidney. Additionally, protective and regenerative effects, 
of both ethanolic extract and seeds, after the CCl4 administration were assessed. 
 
4.1. Hepatic evaluation 
4.1.1. Effects of S. ramosissima ethanolic extract and seeds 
Table 4 summarises the hepatic changes on mice treated with SREE and SRS 
during 3 weeks. Figure 2 shows the main histopathological findings. 
Table 4 - Frequency of hepatic histopathological features in groups treated with SREE and SRS per se. 
 Group treatment 
Histopathological findings Control group Group II Group III 
Hydropic degeneration/vacuolar change 0 4 0 
Disorganisation of hepatic parenchyma 0 4 2 
Inflammatory foci 0 1 1 
Haemorrhages 0 3 1 
Focal necrosis 0 0 0 
Lesions were rated as 0: not present, 1: minimal, 2: mild, 3: moderate and 4: marked. 
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Liver sections from negative control group revealed normal architecture of the 
parenchyma (Fig. 2A). On the other hand, the groups treated with 50 mg/kg of SREE per 
se exhibited significant changes, mainly severe and diffuse hydropic degeneration of 
hepatocytes, with subsequent loss of their radial arrangement (Fig. 2B). Animals treated 
with 2000 mg/kg of SRS per se showed no hepatocyte degeneration, although some loss of 
parenchymal structure and prominence of microvesicules along the focally widened 
sinusoids between the hepatocyte plaques could be observed (Fig. 2C). 
 
  
 
Figure 2 - Light microphotographs of liver sections (H&E stain, 400× original magnification): A) 
control group; B) SREE-treated group; C) SRS-treated group. (CV: central vein,     : haemorrhage,     
: microvesicules). 
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4.1.2. Protection studies 
Table 5 summarises the hepatic changes on mice treated with SREE or SRS during 
3 weeks followed by CCl4 administration. Figure 3 shows the main histopathological 
findings. 
Table 5 - Frequency of hepatic histopathological features in groups of protection studies. 
 Group treatment 
Histopathological findings Negative Control 
Pos. Control  
(Group IV) 
Group V Group VI 
Hydropic degeneration/ vacuolar change 0 3 4 3 
Disorganisation of hepatic parenchyma 0 3 4 3 
Inflammatory foci 0 1 1 1 
Haemorrhages 0 2 4 2 
Focal necrosis 0 3 4 3 
Lesions were rated as 0: not present, 1: minimal, 2: mild, 3: moderate and 4: marked. 
 
The CCl4-affected organs displayed hepatocyte necrosis within the centrilobular 
zone as the predominant histopathologic lesion, together with parenchymal disorganisation 
and hepatocellular degeneration, as evidenced by histological changes (Figs. 3B). [SRS + 
CCl4]-treated group (Group VI) revealed similar histological pattern as the positive control 
group, with a more pronounced microvesicular fatty change (Fig. 3D), whereas the livers 
from [SREE + CCl4]-treated mice (Group V) showed a multiple lesion profile, within the 
group: animals either exhibited centrilobular necrosis plus reasonably degenerated 
periportal zone, exhibited a nearly intact centrilobular zone plus severe periportal 
hepatocyte degeneration (Fig. 3C), or no necrosis but only hepatocyte degeneration. 
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Figure 3 - Microphotographs of hepatic sections (H&E stain, 400× original magnification): A) negative 
control group; B) [Water + CCl4] control group; C) [SREE + CCl4]-treated group; D) [SRS + CCl4]-
treated group. (CV: central vein, PV: portal vein, N: necrosis,   : hydropic degeneration, ►: 
microvesicules). 
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4.1.3. Regeneration studies 
Table 6 summarises the hepatic changes on mice treated with CCl4 followed by 
SREE or SRS administration during 3 weeks. Figure 4 shows the main histopathological 
findings. 
Table 6 - Frequency of hepatic histopathological features in groups of regeneration studies. 
 Group treatment 
Histopathological findings 
Negative 
Control 
Positive 
Control  
(Group VII) 
Group 
VIII 
Group 
IX 
Hydropic degeneration/vacuolar change 0 2 1 2 
Disorganisation of hepatic parenchyma 0 2 1 1 
Inflammatory foci 0 1 1 2 
Haemorrhages 0 0 0 0 
Focal necrosis 0 0 0 0 
Severity was rated as 0: not present, 1: minimal, 2: mild, 3: moderate and 4: marked. 
 
 
Concerning the positive control group, mild cellular degeneration and an irregular 
structure of hepatocyte cords were evidenced (Fig. 4B), when compared with the negative 
control. The experimental groups revealed a similar hepatic profile, though slightly 
ameliorated in Group VI, whereas liver from Group VII was mainly characterised by 
microgranulomas and pigmented cells randomly distributed throughout the parenchyma 
(Fig. 4C). 
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Figure 4 - Histological sections of liver (H&E stain, 400× original magnification): A) negative control 
group; B) [CCl4 + water] control group; C) [CCl4 + SRS]-treated group. (CV: central vein,     : 
hydropic degeneration,     :granulomatous mass, ►: pigmented cells). 
 
4.2. Renal evaluation 
4.2.1. Effects of S. ramosissima ethanolic extract and seeds 
Table 7 summarises the renal changes on mice treated with SREE and SRS during 
3 weeks. Figure 5 shows the main histopathological findings. 
Table 7 - Frequency of renal histopathological features in groups treated with SREE and SRS per se. 
 Group treatment 
Histopathological findings Negative Control  Group II Group III 
Cellular debris within cortical tubular lumen 0 0 0 
Glomerular structural changes 0 2 2 
Inflammatory foci 1 3 3 
Haemorrhages 0 3 3 
Lesions were rated as 0: not present, 1: minimal, 2: mild, 3: moderate and 4: marked. 
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Renal profile of negative control group evidenced normal features (Fig. 5A). However, 
significant and similar histological alterations were found in both SREE and SRS exposed 
groups: cortical interstitial haemorrhages and inflammatory cell infiltration (Fig. 5B), 
associated with glomerular surrounding zones particularly in SREE-treated mice (Group 
II). Glomerular integrity was slightly compromised in both groups. 
  
Figure 5 - Light micrographs of kidney sections (H&E stain, 400× original magnification): A) negative 
control group; B) SRS-treated group. (G: glomerulus, H: haemorrhage,       : inflammatory focus) 
 
 
4.2.2. Protection studies 
Table 8 summarises the renal changes on mice treated with SREE or SRS during 3 
weeks followed by CCl4 administration. Figure 6 shows the main histopathological 
findings. 
Table 8 - Frequency of renal histopathological features in groups of protection studies. 
 Group treatment 
Histopathological findings 
Negative 
Control 
Pos. 
Control  
(Group IV) 
Group 
V 
Group 
VI 
Cellular debris within cortical tubular lumen 0 4 4 4 
Glomerular structural changes 0 4 2 3 
Inflammatory foci 1 2 2 2 
Haemorrhages 0 1 3 2 
Lesions were rated as 0: not present, 1: minimal, 2: mild, 3: moderate and 4: marked. 
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Kidneys exhibited significant CCl4-induced alterations compared with the negative 
control, mainly severe glomerular structural changes with different grades of degeneration, 
and cell breakdown products and debris within the lumen of the tubules (Fig. 6B). Pre-
treatment with SREE (Group V) revealed the same renal pattern, with the exception of 
significant fewer glomerular changes and increased haemorrhages (Fig. 6C). Pre-treatment 
with SRS (Group VI) differed from the CCl4 control in a slight decrease of glomerular 
changes and in the luminal content, where the latter revealed increased exfoliated cells 
(Fig. 6D). 
  
  
Figure 6 - Renal histological sections (H&E stain, 400× original magnification): A) negative control 
group; B) [Water + CCl4] control group; C) [SREE + CCl4]-treated group; D) [SRS + CCl4]-treated 
group. (G: glomerulus, H: haemorrhage, ►: intact cells,     : cellular debris,       : inflammatory focus). 
 
 
4.2.3. Regeneration studies 
Table 9 summarises the renal changes found on mice treated with CCl4 followed by 
SREE or SRS administration during 3 weeks. Figure 7 shows the main histopathological 
findings. 
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Table 9 - Frequency of renal histopathological features in groups of regeneration studies. 
 Group treatment 
Histopathological findings 
Negative 
Control 
Positive 
Control  
(Group VII) 
Group 
VIII 
Group 
IX 
Cellular debris within cortical tubular lumen 0 0 0 1 
Glomerular structural changes 0 2 2 2 
Inflammatory foci 1 3 3 3 
Haemorrhages 0 3 3 3 
Lesions were rated as 0: not present, 1: minimal, 2: mild, 3: moderate and 4: marked. 
 
Kidney sections treated with CCl4 + SREE revealed no histopathological findings in the 
cortical tubular lumen, nearly as seen in positive control group (Fig. 7B). All treated 
groups were characterised by extensive haemorrhages and leukocyte infiltration foci, and 
Group IX particularly revealed several foci of tubular basophilia (Fig. 7C). 
  
 
Figure 7 - Microphotographs of renal histological sections (H&E stain, 400× original magnification): 
A) negative control group; B) [CCl4 + water] control group; C) [CCl4 + SRS]-treated group. (G: 
glomerulus, H: haemorrhage).
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 IV. Discussion 
The aim of the present experimental study was to explore the potentialities of 
Salicornia ramosissima as a therapeutic agent. The hepatic and renal effects of S. 
ramosissima ethanolic extract and dried seeds were characterised in three different 
settings: their influence per se in normal control animals, their protective and regenerative 
actions under toxic insult (CCl4 exposure). 
Both liver and kidneys were selected in this work since they are intimately related 
organs, as they participate in several metabolic and excretion events. Therefore, any 
abnormality in the liver may also lead to kidney function impairment. 
 
1. Effects of S. ramosissima ethanolic extract and seeds 
The uptake of 50 mg/kg of SREE by mice during 3 weeks (Group II) revealed 
severe hepatotoxicity, and inflammation and haemorrhages in the kidney. However, neither 
significant liver weight nor survival changes were noticed compared with the control. 
Haemorrhage often accompanies acute injury, inflammatory processes or vascular injury 
(Frazier et al. 2012). In this case, both organs confirm the presence of significant damage 
induced by the extract. Consistently, the same histological findings were obtained 
previously (Ferreira et al.  2012). Moreover, a previous study demonstrated high activity of 
Salicornia europaea on A. salina (brine shrimp) and D. magna tests for cytotoxicity. S. 
europaea ethanolic extract caused more than 50% of toxicity in almost all testing (Lellau et 
al. 2003). These tests are frequently used for the screening of toxic compounds from plant 
extracts and consequently to assess biological responses of lethality (Adema 1978; Meyer 
et al. 1982). The biological toxicity verified by SREE is in agreement with the 
aforementioned study. According to these results, the extraction methodology used on S. 
ramosissima possibly retained and concentrated toxic compounds and contaminants.  
 
The uptake of 2000 mg/kg of SRS by mice during 3 weeks (Group III) was based 
on the dosage of a previous study about the effects of Chenopodium quinoa seed extract on 
rats (Meneguetti et al. 2011), a plant from Chenopodiaceae, as well as S. ramosissima. 
Histologically, the hepatic parenchyma exhibited a nearly normal structure and 
organisation, apart from the fact that some sinusoidal spaces revealed to be widened and 
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microvesicular, and this was perceptible only at a higher magnification. An early sign of 
lipidosis could be hypothesised.  
The renal profile of this group is similar to the previously described Group II but 
there was no clear relationship between the minor hepatic changes and the noticeable 
kidney compromise. Contrary to these results, extracts of S. herbacea seeds were reported 
to have antioxidant activity and cytotoxicity against carcinoma cells in vitro (Kang et al. 
2011). Moreover, no renal or liver toxicity was attained with 2000 mg/kg of Hydrolysed 
Quinoa extract (Meneguetti et al. 2011). Therefore, we hypothesise that SRS may contain 
noxious compounds or contaminants, since no purification and extraction method was 
employed in the seeds. The kidney was the most affected organ probably due its 
physiological functions. Despite comprising only a small portion of total body weight, the 
kidney receives approximately 25% of the circulating blood and has an extensive 
reabsorption capacity which ensures that high levels of toxicants are delivered and uptaken 
by renal cells, compared with other organs (Bhadauria et al. 2012). 
 
2. Protection studies 
The main goal of protection studies is to evaluate the preventive action of a 
substance towards an organism stressor. Animal models for hepatic injury are important 
tools for the study of liver physiopathology and extrapolation of related therapeutics into 
human diseases. The chemical chosen for the induction of hepatotoxic (and nephrotoxic) 
action was the CCl4 due to its well-known toxicological specificity and broadened usage in 
laboratory experiments. 
 
For the first positive control group (Group IV), a single low dose of CCl4 was 
administered, and its histopathological effects were noticed 24h after the exposure as 
expected. No significant organ weight or survival changes were noticed compared with the 
negative control. CCl4 is known to cause an increase in liver weight (Uemitsu et al. 1984) 
but the low dose administrated may have not been appropriate to induce such significant 
increase. However, the administration of CCl4 caused significant morphological damage to 
the liver and kidneys, especially to the renal cortex. These findings are consistent with 
those described previously (Bhadauria 2012; Irie et al. 2010; Khan et al. 2009). Indeed, 
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CCl4 bioactivation occurs in the centrilobular zone, the selected site of detoxification. 
CCl4 metabolism begins with the formation of the trichloromethyl free radical (CCl3
∙ ) 
through the action of the cytochrome P450 oxygenase system of the endoplasmic 
reticulum. The major cytochrome isozyme to execute biotransformation of CCl4 is 
CYP2E1, but CYP2B1 and CYP2B2 may also be involved. The resulting CCl3
∙  radical is 
reactive enough to bind covalently to CYP2E1, thus causing its own inactivation. The 
CCl3
∙  radical in the presence of oxygen is transformed into a more reactive radical, the 
trichloromethyl peroxy (CCl3OO
∙) (Weber et al. 2003). Both radicals react with several 
important biological substances (proteins, lipids, nucleic acids and amino acids) having 
preference for fatty acids from membrane phospholipids. This leads to sequential free 
radical reactions until the complete disintegration of the membrane and leakage of 
microsomal enzymes, in a process called lipid peroxidation (Manibusan et al. 2007). 
Meantime, the susceptibility of the kidney to toxicant-induced injury is mediated by 
physiological and biochemical factors. Physiologically, the large luminal surface area, high 
renal reabsorption capacity and the ability to concentrate solutes can result in 
extraordinarily increased amount of toxicant exposure and its metabolites (Frazier et al. 
2012). Biochemical factors include the presence of several biotransformation enzymes 
which mediate the formation of toxic metabolites and reactive intermediates. The proximal 
tubule is the main site of xenobiotic transformation and is particularly sensitive to chemical 
insult since it contains cytochrome P450 enzymes, mainly the CCl4-metabolising enzyme 
CYP2E1 (Hu et al. 1990). CCl4-induced tubular necrosis leads to the detachment of 
tubular epithelial cells from the basement membrane (Khan et al. 2009), which form 
aggregates that can obstruct filtrate flow and increase intraluminal pressure and decrease 
glomerular filtration rate (GFR), inducing the back leak of filtrate into the interstitium, 
which further decreases GFR (Goligorsky et al. 1993). Another factor is the renal 
sensibility to vasoactive substances. The vasoconstriction induced by CCl4 produces an 
ischemic local environment, which leads to cellular injury by deteriorating the membrane 
integrity (Khan et al. 2010). This fact, added to low GFR, may ultimately cause glomerular 
dysfunction. Accordingly, our results show that the glomerular function and the capacity of 
tubular absorption may have been altered with CCl4 exposure, leading to functional 
overloading of nephrons with subsequent renal failure as also reported (Khan et al. 2009).  
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Concerning experimental groups, pre-treatment with SREE (Group V) provided 
different hepatic responses within the group, 24h after CCl4 administration. The 
centrilobular hepatocytes either (a) appeared nearly normal with SREE-typical pattern on 
adjacent periportal zone, (b) revealed CCl4-necrosis with moderately disorganised 
architecture of periportal zone, and (c) only SREE-pattern was attained.  
Oppositely, a previous study on the halophyte Sarcocornia perennis subsp. 
perennis, which is taxonomically close related to S. ramosissima, demonstrated a 
protective effect against CCl4-treated mice, mainly on liver and spleen, although the plant 
per se revealed testicular toxicity (Pinto 2011). Moreover, another member of the 
Chenopodiaceae, the halophyte Suaeda maritima, exhibited significant hepatoprotection 
against concanavalin-A-exposed rats (Ravikumar et al. 2011). 
The most interesting fact about the hepatic results of the present work is that these 
complete unexpected interactions between SREE and CCl4 occurred in the same 
experimental conditions; therefore these differences can only be explained with molecular 
mechanisms, where specific compound interactions occur. Consequently, these findings 
were probably due to the multitude of different chemical compounds present in the extract, 
since they can act synergistically, enhancing the hepatic pathological features, or 
antagonistically to CCl4 (Venkataramanan et al. 2006). Through the results attained from 
the surprising histological finding (a), we also hypothesise that CCl4 nature can be even 
modified when its hepatic site of action is previously injured by SREE toxic compounds, 
reversing CCl4 toxicological action into a repairing one. Alternatively, and in agreement 
with the histological finding (b), a previous report demonstrated an increased CCl4-
induced hepatotoxicity by Salvia officinalis tea and, unlike SREE, it does not trigger any 
toxicity per se. Pre-treatment with the S. officinalis tea for 14 days before CCl4 
administration exacerbated centrilobular necrosis versus water drinking mice, and 
increased the expression and activity of CYP2E1 (Lima et al. 2007). An induction or an 
over-expression of CYP2E1 is correlated with higher CCl4 toxicity as CCl4 becomes toxic 
upon activation primarily through this cytochrome (Weber et al. 2003). 
Nevertheless, each different response may depend on the herb compound 
concentration, their sufficient amount intake at a given time period and the genetic 
susceptibility of the animals, so that the compounds can take beneficial and/or adverse 
effect properly (Yang et al. 2006). Furthermore, the liver handles compounds through a 
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complex network of feedback mechanisms, which are interconnected by similar regulatory 
elements and substrates (Venkataramanan et al. 2006). 
On the other hand, the kidneys exhibited uniform morphological changes among 
the group, and differed from the positive control in the increased haemorrhage extent and 
decreased number of degenerated glomeruli. Although SREE have failed to protect the 
CCl4-affected cortical tubules, at least it partially inhibited the extension of the lesions into 
the glomerulus. As mentioned earlier, SREE per se caused mild glomerular changes. 
Altogether, these evidences may support the idea of SREE-induced damage in normal state 
of the organism, whereas under extreme cellular stress, the extract shows an opposite effect 
and protects discriminately some renal areas, probably by preventing excessive CCl4 
vasoconstriction and reabsorption. 
 
Regarding SRS + CCl4-treated animals (Group VI), prior seed administration did 
not positively influence the histological outcome in the liver, as it failed to reduce the 
extent of CCl4-induced injury. Furthermore, SRS enhanced CCl4-induced fatty vacuolar 
changes around all the parenchyma, suggesting an increased lipidosis. In contradiction to 
these results, a previous study on a seed extract of Spinacia oleracea, also a 
Chenopodiaceae, demonstrated hepatoprotective effect against CCl4-induced injury. 
Through acute toxicity in vitro studies, this extract was also found to be safe up to 2000 
mg/kg (Jain et al. 2012). 
In the renal tissue, similar CCl4-features occurred in Group VI, with the exception 
of the additional cellular content inside the tubular lumen, suggesting exfoliated tubule 
cells. Viable and non-viable renal tubular epithelial cells may also be sloughed into the 
tubular lumen, which promotes the loss of epithelial integrity (Racusen 1998). In addition 
to not conferring protection to tubular epithelium and yet somewhat intensifying the 
lesions, SRS did not significantly reduce the number of degenerated glomeruli, compared 
with SREE+CCl4-treated group. All these findings show the SRS incapacity to prevent a 
toxicological insult and the inherent oxidative responses. 
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3. Regeneration studies 
The main goal of the following regeneration studies is to simulate human diseases 
in animal models and to evaluate the potential curative and therapeutic action of the tested 
substances. 
For the second positive control group (Group VII), the same single dose of CCl4 
was administered and its histopathological effects were evaluated after 3 weeks. 
Histologically, a certain degree of recovery was observed in hepatocytes and liver lobular 
arrangement, although some cell degeneration still persists. Indeed, the liver has a strong 
capacity for regeneration and the loss of hepatic tissue from the action of toxic compounds 
initiates a mechanism by which the surviving hepatocytes undergo promitogenic activity, 
until the original mass of tissue and its functions are restored. (Mescher 2009).  
CCl4 elicits two opposing responses, tissue repair and tissue damage. Normally, 
with lower acute doses of CCl4, hepatocellular recovery will begin as soon as centrilobular 
necrosis starts to become evident. To accomplish this, cells must have sufficient energy 
supplies and receive no further injury from the same level of toxic exposure. Since the 
single dose of the present study was low, CCl4 did not deplete cellular ATP levels 
completely, as earlier reported for higher dosages (Soni et al. 1994), and enabled the 
regenerative process take its course. 
Concerning the kidneys, necrotic tubular injury was clearly decreased, although 
significant haemorrhage and inflammatory foci were still sustained after this time period. 
Normally after an acute chemical insult, the proximal tubular epithelium can be recovered 
within 5 to 7 days (Frazier et al. 2012), through the sequential process of dedifferentiation, 
migration, proliferation and redifferentiation of surviving cells which restores the tubular 
cell layer and function (Nony et al. 2003). After 21 to 28 days the tubules show a fully 
mature epithelium, functionally normal (Frazier et al. 2012). Our findings on Group VII 
are consistent with this outcome, and by this time CCl4 may be already completely 
excreted from the organism. However, inflammatory processes remains and obviously 
more time would be needed for a complete recovery. 
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With regard to experimental groups, post-treatment with SREE (Group VIII) 
provided similar but ameliorated histological hepatic features.   
It would be expected a hepatic histological profile similar to the Group II, though 
this has not happened. Previous reports indicated that pre-treatment with low CCl4 doses 
before a lethal dose from the same toxicant, evidences an autoprotective effect (Pound et 
al. 1975). Moreover, heteroprotection can be equally achieved, preventing the action of the 
second-administered compound with higher dose (Chanda et al. 1995). This may be due to 
the fact that while hepatocytes undergo regenerative processes caused by the first toxicant, 
the CCl4, all other mechanisms of injury progression induced by SREE toxic compounds, 
in this case, seem to be inhibited. On the other hand, and assuming that the extract contains 
a variety of beneficial compounds, the action of antioxidants will probably be more 
emphasised, since toxic compounds may be supressed. This hypothesis may explain the 
faster hepatic recovery from the combined CCl4 and SREE-induced hepatotoxicity in this 
group, compared with the respective positive control. 
While hepatic improvements were evident, the renal structure of this group was 
similar to the positive control. It is possible that beneficial compounds may have not 
reached the kidney within this time frame. 
 
Post-treatment with SRS (Group IX) caused high mortality rate within the group. 
The histopathological evaluation of the remaining animals revealed a slightly aggravated 
morphology of the liver compared with the positive control and featured no additional 
recovery. In fact, some small granulomatous-like cell masses were observed, associated 
with yellow-brown pigmented cells. Granulomatous changes are most probably caused by 
precipitated poor water-soluble metabolites (Greaves 2007). Similar findings were 
described previously (Sobol et al. 2006). Pigmentation can result from cellular and 
erythryoid breakdown products, lipid peroxidation of cell membranes or altered heme 
metabolism (Thoolen et al. 2010). Circulatory disorders and xenobiotic treatment and may 
induce lipofuscin, hemosiderin or porphyrin accumulation in hepatic tissue (Greaves 
2007). A previous study showed microgranulomas and lipofuscin pigments concomitantly 
present in the liver from beagle dogs after a chronic drug treatment, suggesting that basal 
maintenance and turnover of membranes were disturbed, with a subsequent increased 
accumulation of degradation products (Walsh et al. 1999). The pigmentation nature in the 
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present study is still unknown, although it is believed to result from the long-term and high 
dose exposure of SRS, which deprived hepatocytes of its full recovery and enhanced liver 
impairment, previously under stress conditions. 
Concerning the kidneys, they presented several foci of tubular basophilia, 
suggesting an earlier sign of tubular regeneration. These basophilic cells are characterised 
by high mitotic activity and are normally present in the reconstructive tissue after 5 to 7 
days of tubular cell necrosis, where the basement membrane remained intact (Frazier et al. 
2012). However, in this experimental group, these cells persisted in the renal tissue during 
22 days, indicating that, although the epithelial lining is complete, epithelial cell turnover 
persisted for a considerable time (Haagsma et al. 1980).  
This evidence demonstrates that SRS treatment for 22 days after CCl4 
administration delayed the normal regenerative process and caused cell abnormalities, 
mainly in the liver. These facts may be some of the reasons behind the low survival rate 
associated with this group. 
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 V. Conclusions and Future Perpectives 
Based on the study of S. ramosissima potential as a therapeutic agent, the current 
approach demonstrated some adverse histopathological effects. The histological data of the 
present work has shown that 50 mg/kg of S. ramosissima ethanolic extract revealed to be 
hepatotoxic and nephro-inflammatory; the seeds of this species at a dose of 2000 mg/kg 
caused significant renal inflammation and a slight hepatic changes. 
 
Through histological analysis of CCl4-subjected mice, it can be also inferred that 
neither S. ramosissima ethanolic extract nor their seeds were able to effectively protect 
CCl4-induced injury on liver and kidney, on considered experimental conditions. 
S. ramosissima ethanolic extract was able to promote mild regeneration on CCl4-
induced liver injury, but not in the kidneys. The extent of recovery achieved in this study 
exclusively happened through kidney’s own regenerative processes. 
The seeds of the studied species were unable to successfully promote regeneration 
on CCl4-induced injury on liver and kidney, on considered experimental conditions. 
Contrariwise, it had a deleterious reverse effect, causing death possibly through 
impairment of normal function. 
 
The findings of the present work raised numerous questions regarding the efficacy 
of S. ramosissima as a protective and regenerative agent of hepatorenal toxicity. 
For this reason, further research is required in order to elucidate the effects of 
extracts of this plant. The following strategies should be addressed: 
• New methodological approaches evidencing the precise biological 
mechanisms which are responsible for the plant-induced effects, such as 
histochemistry, immunohistochemistry and oxidative stress enzyme assays. 
• Dose-dependent toxicological assays with the S. ramosissima extract and 
seeds, along with several times of exposure; 
• The fractioning of the extract and isolation of its phytochemical compounds 
or potential contaminants, in order to establish a relationship between their 
chemical structure and the biological activities tested; 
• Preparation of a seed extract and compound isolation for the same reasons 
above. 
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Although the biological mechanisms of S. ramosissima are not fully understood, the 
evidences suggest the pertinence of developing further research on this spontaneous 
halophyte that inhabits salt marshes and salt pans of Ria the Aveiro and is accessible to the 
general population. 
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Salicornia ramosissima J. Woods (Chenopodiaceae), included in the species aggregate S. europaea agg., is 
an annual succulent halophyte and one of the most salt tolerant plants, broadly distributed in the salt marshes 
and salt pans of Ria de Aveiro and in many others of the Iberian Peninsula [1]. Salicornia L. has been used 
not only as a seasoned vegetable, salad and fermented food in coastal areas of Europe and Asia [2], but also 
as folk medicine for disorders such as constipation, obesity and diabetes [3]. To corroborate this, the 
literature reports immunomodulatory, antioxidative, anti-inflammatory, anti-hyperlipidemic and antidiabetic 
effects [4]. Moreover, some bioactive compounds from its aerial parts were recently isolated and identified, 
exhibiting also antioxidant and cytotoxic activities [2, 5].  
Factors such as the proper botanical identification, season and harvest site, extraction and purification 
methods, characterisation of the active constituents and the extract effects in a dose-and time-dependent 
manner are crucial to assess the therapeutic potential of herbal extracts [6]. The aim of this study was to 
investigate the possible hepatic and renal effects of an ethanolic extract of S. ramosissima on mice. 
 
Aerial portions of S. ramosissima were collected from a salt pan in Ria de Aveiro (Portugal). The ethanolic 
extract (50 mg/kg b.w.) was orally administered, during 3 weeks, to male ICR-CD1 mice, purchased from 
Harlan (Spain). Control group was also considered. Liver and kidney were collected and prepared for 
histology. Animal procedures were followed according to guidelines for ethics and animal care. 
Central and portal vein congestion and severe hydropic changes of the hepatocytes were noted in the liver of 
exposed group, compared with controls (Figs. 1A, 1B). Renal profile of control group evidenced normal 
features (Figs.1C, 1E). However, significant histological alterations were found in the exposed group: 
cortical interstitial haemorrhages (Fig. 1D), inflammatory cell infiltration and tubular cell degeneration 
within medulla and cortico-medullary junction (Fig. 1F). 
In conclusion, this pilot study has demonstrated considerable effects in the mouse metabolism of S. 
ramosissima ethanolic extract, with significant hepatic and renal lesions. Further studies are needed to 
correlate these data with isolated active constituents for a more reliable evaluation of the potential of this 
species.  
 
[1] Silva H. et al., Ecol Res 22: 125–134, 2007 
[2] Kim J. Y. et al., Food Chem 125: 55–62, 2011 
[3] Lee K.Y. et al., J Ethnopharmacol 103(3):372–378, 2006 
[4] Rhee M. H. et al., J Med Plants Res 3(8): 548–555, 2009 
[5] Wang Q. et al., Fitoterapia 83: 742–749, 2012 
[6] Bandaranayake W. M., Modern Phytomedicine: Turning Medicinal Plants into Drugs 25–57, 
2006 
 
 67 
 
 VII. Appendix 
  
 
   
 
   
 
Fig 1. Light microphotographs of liver (A, B) and kidney sections (C-F) (H&E stain, 400× original 
magnification): A, C and E) Control group; B, D and F) S. ramosissima ethanolic extract-treated group.  
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